Alport syndromes: Phenotypic heterogeneity of progressive hereditary nephritis

Pediatric Nephrology

Volumn 14, Issue 6, 2000, Pages 502-512

  Kashtan, Clifford E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Alport syndrome; Extrarenal disease; Heterogeneity; Molecular genetics

Indexed keywords

ALPORT SYNDROME; BASEMENT MEMBRANE; BIOCHEMISTRY; FEMALE; GENETIC HETEROGENEITY; HUMAN; MALE; MOLECULAR GENETICS; NEPHRITIS; NEUROPATHY; NONHUMAN; PERCEPTION DEAFNESS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; ULTRASTRUCTURE;

EID: 0034110693     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670050804     Document Type: Review

References (120)

1. Zhou J, Reeders ST (1996) The a chains of type IV collagen. Contrib Nephrol 117:80-105
2. Dolz R, Engel J, Kuhn K (1988) Folding of collagen IV. Eur J Biochem 178:357-366
3. Timpl R, Wiedernann H, Delden V van, Furthmayr H, Kuhn K (1981) A network model for the organization of type IV collagen molecules in basement membranes. Eur J Biochem 120: 203-211
4. Yurchenco PD, Tsilibary EC, Charonis AS, Furthmayr H (1986) Models for the self-assembly of basement membrane. J Histochem Cytochem 34:93-102
5. Lemmink HH, Schröder CH, Monnens LAH, Smeets HJM (1997) The clinical spectrum of type IV collagen mutations. Hum Mutat 9:477-499
6. Jefferson JA, Lemmink HH, Hughes AE, Hill CM, Smeets HJ, Doherty CC, Maxwell AP (1997) Autosomal dominant Alport syndrome linked to the type IV collagen alpha 3 and alpha 4 genes (COL4A3 and COL4A4). Nephrol Dial Transplant 12: 1595-1599
7. Kuvaniemi H, Tromp G, Prockop DJ (1997) Mutations in fibrillar collagens (types I, II, III, and XI), fibril-associated collagen (type IV), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels. Hum Mutat 9:300-315
8. Ding J, Stitzel J, Berry P, Hawkins E, Kashtan C (1995) Autosomal recessive Alport syndrome: mutation in the COL4A3 gene in a woman with Alport syndrome and posttransplant antiglomerular basement membrane nephritis. J Am Soc Nephrol 5:1714-1717
9. Knebelmann B, Forestier L, Drouot L, Quinones S, Chuet C, Benessy F, Saus J, Antignac C (1995) Splice-mediated insertion of an Alu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome. Hum Mol Genet 4:675-679
10. Lemmink HH, Mochizuki T, Heuvel LPWJ van den, Schroder CH, Barrientos A, Monnens LAH, Oost BA van, Brunner HG, Reeders ST, Smeets HJM (1994) Mutations in the type IV collagen α3 (COL4A3) gene in autosomal recessive Alport syndrome. Hum Mol Genet 3:1269-1273
11. Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler MC, Pirson Y, Verellen-Dumoulin C, Chan B, Schroeder CH, Smeets HJM, Reeders ST (1994) Identification of mutations in the α3(IV) and α4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 8:77-82
12. Boye E, Mollet GFL, Cohen-Solal L, Heidet L, Cochat P, Grunfeld J-P, Palcoux J-B, Gubler M-C, Antignac C (1998) Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome. Am J Hum Genet 63:1329-1340
13. Lemmink HH, Nillesen WN, Mochizuki T, Schröder CH, Brunner HG, Oost BA van, Monnens LAH, Smeets HJM (1996) Benign familial hematuria due to mutation of the type IV collagen α4 gene. J Clin Invest 98:1114-1118
14. Yoshioka K, Hino S, Takemura T, Maki S, Wieslander J, Takekoshi Y, Makino H, Kagawa M, Sado Y, Kashtan CE (1994) Type IV collagen α5 chain: normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am J Pathol 144:986-996
15. Peissel B, Geng L, Kalluri R, Kashtan C, Rennke HG, Gallo GR, Yoshioka K, Sun MJ, Hudson BG, Neilson EG, Zhou J (1995) Comparative distribution of the α1(IV), α5(IV) and α6(IV) collagen chains in normal human adult and fetal tissues and in kidneys from X-linked Alport syndrome patients. J Clin Invest 96:1948-1957
16. Nakanishi K, Yoshikawa N, Iijima K, Kitagawa K, Nakamura H, Ito H, Yoshioka K, Kagawa M, Sado Y (1994) Immunohistochemical study of α1-5 chains of type IV collagen in hereditary nephritis. Kidney Int 46:1413-1421
17. Kashtan CE, Kleppel MM, Gubler MC (1996) Immunohistologic findings in Alport syndrome. Contrib Nephrol 117:142-153
18. Kashtan CE, Kim Y (1992) Distribution of the α1 and α2 chains of collagen IV and of collagens V and VI in Alport syndrome. Kidney Int 42:115-126
19. Kagawa M, Kishiro Y, Naito I, Nemoto T, Nakanishi H, Ninomiya Y, Sado Y (1997) Epitope-defined monoclonal antibodies against type-IV collagen for diagnosis of Alport's syndrome. Nephrol Dial Transplant 12:1238-1241
20. Gubler MC, Knebelmann B, Beziau A, Broyer M, Pirson Y, Haddourn F, Kleppel MM, Antignac C (1995) Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution. Kidney Int 47:1142-1147
21. Kashtan CE (1998) Alport syndrome and thin glomerular basement membrane disease. J Am Soc Nephrol 9:1736-1750
22. Kashtan CE, Michael AF (1996) Perspectives in clinical nephrology: Alport syndrome. Kidney Int 50:1445-1463
23. Butkowski RJ, Wieslander J, Kleppel M, Michael AF, Fish AJ (1989) Basement membrane collagen in the kidney: regional localization of novel chains related to collagen IV. Kidney Int 35:1195-1202
24. Cosgrove D, Kornak JM, Samuelson G (1996) Expression of basement membrane type IV collagen chains during postnatal development in the murine cochlea. Hear Res 100:21-32
25. Kalluri R, Gattone VH, Hudson BG (1998) Identification and localization of type IV collagen chains in the inner ear cochlea. Connect Tissue Res 37:143-150
26. Kleppel MM, Kashtan C, Sand PA, Wieslander J, Michael AF (1989) Distribution of familial nephritis antigen in normal tissue and renal basement membranes of patients with homozygous and heterozygous Alport familial nephritis: relationship of familial nephritis and Goodpasture antigens to novel collagen chains and type IV collagen. Lab Invest 61:278-289
27. Kleppel MM, Michael AF (1990) Expression of novel basement membrane components in the developing human kidney and eye. Am J Anat 187:165-174
28. Kleppel MM, Santi PA, Cameron JD, Wieslander J, Michael AF (1989) Human tissue distribution of novel basement membrane collagen. Am J Pathol 134:813-825
29. Ninomiya Y, Kagawa M, Iyama K, Naito I, Kishiro Y, Seyer JM, Sugimoto M, Oohashi T, Sado Y (1995) Differential expression of two basement membrane collagen genes, COL4A6 and COL4A5, demonstrated by inimunofluorescence staining using peptide-specific monoclonal antibodies. J Cell Biol 130: 1219-1229
30. Miner JH, Sanes JR (1994) Collagen IV α3, α4 and α5 chains in rodent basal laminae: sequence, distribution, association with laminins, and developmental switches. J Cell Biol 127: 879-891
31. Kalluri R, Shield CF, Todd P, Hudson BG, Neilson EG (1997) Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J Clin Invest 99:2470-2478
32. Cheong HI, Kashtan CE, Kim Y, Kleppel MM, Michael AF (1994) Immunohistologic studies of type IV collagen in anterior lens capsules of patients with Alport syndrome. Lab Invest 70:553-557
33. Nomura S, Naito I, Fukushima T, Tokura T, Kataoka N, Tanaka I, Tanaka H, Osawa G (1998) Molecular genetic and immunohistochemical study of autosomal recessive Alport's syndrome. Am J Kidney Dis 31:E4.1
34. Lees G, Helman RG, Kashtan CE, Michael AF, Homco LD, Millichamp NJ, Ninomiya Y, Sado Y, Kim Y (1998) A model of autosomal recessive Alport syndrome in English cocker spaniel dogs. Kidney Int 54:706-719
35. Naito I, Kawai S, Nomura S, Sado Y, Osawa G (1996) Relationship between COL4A5 gene mutation and distribution of type IV collagen in male X-Iinked Alport syndrome. Kidney Int 50:304-311
36. Kleppel MM, Kashtan CE, Butkowski RJ, Fish AJ, Michael AF (1987) Alport familial nephritis: absence of 28 kilodalton non-collagenous monomers of type IV collagen in glomerular basement membrane. J Clin Invest 80:263-266
37. Kleppel MM, Fan WW, Cheong HI, Michael AF (1992) Evidence for separate networks of classical and novel basement membrane collagen: characterization of α3(IV)-Alport antigen heterodimers. J Biol Chem 267:4137-4142
38. Gunwar S, Ballester F, Noelken M, Sado Y, Ninomiya Y, Hudson B (1998) Glomerular basement membrane. Identification of a novel disulfide-cross-linked network of alpha3, alpha4. and alpha5 chains of type IV collagen and its implications for the pathogenesis of Alport syndrome. J Biol Chem 273: 8767-8775
39. Prockop DJ (1992) Mutations in collagen genes as a cause of connective-tissue diseases. N Engl J Med 326:540-546
40. Thorner PS, Zheng K, Kalluri R, Jacobs R, Hudson BG (1996) Coordinate gene expression of the α3, α4 and α5 chains of collagen type IV: evidence from a canine model of X-linked nephritis with a COL4A5 gene mutation. J Biol Chem 271: 13821-13828
41. Nakanishi K, Yoshikawa N, Iijima K, Nakamura H (1996) Expression of type IV collagen α3 and α4 chain mRNA in X-linked Alport syndrome. J Am Soc Nephrol 7:938-945
42. Sasaki S, Zhou B, Fan WW, Kim Y, Barker DF, Derision JC, Atkin CL, Gregory MC, Zhou J, Segal Y, Sado Y, Ninomiya Y, Michael AF, Kashtan CE (1998) Expression of mRNA for type IV collagen α1, α5 and α6 chains by cultured dermal fibroblasts from patients with X-linked Alport syndrome. Matrix Biol 17:279-291
43. Miner JJ, Sanes JR (1996) Molecular and functional defects in kidneys of mice lacking collagen α3(IV): implications for Alport syndrome. J Cell Biol 135:1403-1413
44. Cosgrove D, Meehan DT, Grunkerneyer JA, Kornak JM, Sayers R, Hunter WJ, Samuelson GC (1996) Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome. Genes Dev 10:2981-2992
45. Mazzucco G, Barsotti P, Muda AO, Fortunato M, Mihatsch M, Torri-Tarelli L, Renieri A, Faraggiana T, De Marchi M, Monga G (1998) Ultrastructural and immunohistochemical findings in Alport's syndrome: a study of 108 patients from 97 Italian families with particular emphasis on COL4A5 gene mutation correlations. J Am Soc Nephrol 9:1023-1031
46. Knebelmann B, Breillat C, Forestier L, Arrondel C, Jacassier D, Giatras J, Druout L, Deschennes G, Grunfeld JP, Broyer M, Gubler MC, Antignac C (1996) Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome. Am J Hum Genet 59:1221-1232
47. Churg J, Sherman RL (1973) Pathologic characteristics of hereditary nephritis. Arch Pathol 95:374-379
48. Hinglais N, Grunfeld J-P, Bois LE (1972) Characteristic ultrastructural lesion of the glomerular basement membrane in progressive hereditary nephritis (Alport's syndrome). Lab Invest 27:473-487
49. Spear GS, Slusser RJ (1972) Alport's syndrome: emphasizing electron microscopic studies of the glomerulus. Am J Pathol 69: 213-222
50. Jansen B, Thorner P, Baumal R, Valli V, Maxie MG, Singh A (1986) Samoyed hereditary glomerulopathy (SHG): evolution of splitting of glomerular capillary basement membranes. Am J Pathol 125:536-545
51. Rumpelt H-J (1980) Hereditary nephropathy (Alport syndrome): correlation of clinical data with glomerular basement membrane alterations. Clin Nephrol 13:203-207
52. Meleg-Smith S, Magliato S, Cheles M, Garola RE, Kashtan CE (1998) X-linked Alport syndrome in females. Hum Pathol 29:404-408
53. Plant KE, Green PM, Vetrie D, Flinter FA (1999) Detection of mutations in COL4A5 in patients with Alport syndrome. Hum Mutat 13:124-132
54. Nakanishi K, Iijima K, Kuroda N, Inoue Y, Sado Y, Nakamura H, Yoshikawa N (1998) Comparison of α5(IV) collagen chain expression in skin with disease severity in women with X-linked Alport syndrome. J Am Soc Nephrol 9:1433-1440
55. Lees G, Helman RG, Kashtan CE, Michael AF, Homco LD, Millichamp NJ, Camacho ZT, Templeton JW, Ninomiya Y, Sado Y, Kim Y (1999) A new form of X-linked dominant hereditary nephritis in dogs. Am J Vet Res 60:373-383
56. Guo C, Van Damme B, Vanrenterghem Y, Devriendt K, Cassiman J-J, Marynen P (1995) Severe Alport phenotype in a woman with two missense mutations in the same COL4A5 gene and preponderant inactivation of the X chromosome carrying the normal allele. J Clin Invest 95:1832-1837
57. Vetrie D, Flinter F, Bobrow M, Harris A (1992) X inactivation patterns in females with Alport's syndrome: a means of selecting against a deleterious gene? J Med Genet 29:663-666
58. Kapoor S, Dasgupta J (1979) Chromosomal anomaly in a female patient with anterior lenticonus. Ophthalmologica 179: 271-275
59. Gregory MC, Atkin CL (1993) Alport syndrome. In: Schrier RW, Gottschalk CW (eds) Diseases of the kidney. Little Brown, Boston, pp 571-591
60. Renieri A, Meroni M, Sessa A, Battini G, Serbelloni P, Torri-Tarelli L, Seri M, Galli L, De Marchi M (1994) Variability of clinical phenotype in a large Alport family with gly1143-ser change of collagen α5(IV) chain. Nephron 67:444-449
61. Grunfeld J-P, Noel LH, Hafez S, Droz D (1985) Renal prognosis in women with hereditary nephritis. Clin Nephrol 23: 267-271
62. Barker DF, Pruchno CJ, Xiang X, Atkin CL, Stone EM, Deison JC, Fain PR, Gregory MC (1996) A mutation causing Alport syndrome with tardive hearing loss is common in the western United States. Am J Hum Genet 58:1157-1165
63. Finielz P, Cartault F, Chuet C, Genin R (1998) Alport syndrome in Reunion Island: phenotypic heterogeneity of the recessive-autosomal form. Nephron 79:237
64. Pochet JM, Bobrie G, Landais P, Goldfarb B, Grunfeld J-P (1989) Renal prognosis in Alport's and related syndromes: influence of the mode of inheritance. Nephrol Dial Transplant 4:1016-1021
65. Harvey SJ, Zheng K, Sado Y, Naito I, Ninomiya Y, Jacobs RM, Hudson BG, Thorner PS (1998) Role of distinct type IV collagen networks in glomerular development and function. Kidney Int 54:1857-1866
66. Cosgrove D, Samuelson G, Meehan DT, Miller C, McGee J, Walsh EJ, Siegel M (1998) Ultrastructural, physiological, and molecular defects in the inner ear of a gene knockout mouse model of autosomal Alport syndrome. Hear Res 121:84-98
67. Muda AO, Rahimi S, Renieri A, Rizzoni G, Massella L, Faraggiana T (1997) Ultrastructural immunocytochemistry of collagenous and non-collagenous proteins in fast-frozen, freeze-substituted, and low-temperature-embedded renal tissue in Alport syndrome. J Pathol 182:465-474
68. Kashtan CE, Gubler MC, Sisson-Ross S, Mauer M (1998) Chronology of renal scarring in males with Alport syndrome. Pediatr Nephrol 12:269-274
69. Callis L, Vila A, Carrera M, Nieto J (1999) Long-term effects of cyclosporine A in Alport's syndrome. Kidney Int 55: 1051-1056
70. Kashtan CE, McEnery PT, Tejani A, Stablein DM (1995) Renal allograft survival according to primary diagnosis: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 9:679-684
71. Peten E, Pirson Y, Cosyns J-P, Squifflet J-P, Alexandre GPJ, Noel L-H, Grunfeld J-P, Ypersele de Strihou C van (1991) Outcome of thirty patients with Alport's syndrome after renal transplantation. Transplantation 52:823-826
72. Gobel J, Olbricht CJ, Offner G, Helmchen U, Repp H, Koch KM, Frei U (1992) Kidney transplantation in Alport's syndrome: long-term outcome and allograft anti-GBM nephritis. Clin Nephrol 38:299-304
73. Noel LH, Gubler MC, Bobrie G, Savage COS, Lockwood CM, Grunfeld JP (1989) Inherited defects of renal basement membranes. Adv Nephrol 18:77-94
74. Hayes DK, Majeski JA, Alexander JW, Rajagopalan PR, Fitts CT, First MR, Munda R, Fidler JP (1985) Renal transplantation in Alport's syndrome. Am Surg 51:414-417
75. Berardinelli L, Pozzoli E, Raiteri M, Canal R, Tonello G, Tarantino A, Vegeto A (1990) Renal transplantation in Alport's syndrome: personal experience in twelve patients. Contrib Nephrol 80:131-134
76. McCoy RC, Johnson HK, Stone WJ, Wilson CB (1982) Absence of nephritogenic GBM antigen(s) in some patients with hereditary nephritis. Kidney Int 21:642-652
77. Brainwood D, Kashtan C, Gubler MC, Turner AN (1998) Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation. Kidney Int 53: 762-766
78. Kalluri R, Weber M, Netzer K-O, Sun MJ, Neilson EG, Hudson BG (1994) COL4A5 gene deletion and production of post-transplant anti-α3(IV) collagen alloantibodies in Alport syndrome. Kidney Int 45:721-726
79. Dehan P, Van Den Heuvel LPWJ, Smeets HJM, Tryggvason K, Foidart J-M (1996) Identification of post-transplant anti-a5(IV) collagen alloantibodies in X-linked Alport syndrome. Nephrol Dial Transplant 11:1983-1988
80. Heuvel LPWJ van de, Schroder CH, Savage COS, Menzel D, Assmann KJM, Monnens LAH, Veerkamp JH (1989) The development of anti-glomerular basement membrane nephritis in two children with Alport's syndrome after renal transplantation: characterization of the antibody target. Pediatr Nephrol 3: 406-413
81. Ding J, Zhou J, Tryggvason K, Kashtan CE (1994) COL4A5 deletions in three patients with Alport syndrome and post-transplant antiglomerular basement membrane nephritis. J Am Soc Nephrol 5:161-168
82. Antignac C, Knebelmann B, Druout L, Gros F, Deschenes G, Hors-Cayla M-C, Zhou J, Tryggvason K, Grunfeld J-P, Broyer M, Gubler M-C (1994) Deletions in the COL4A5 collagen gene in X-linked Alport syndrome: characterization of the pathological transcripts in non-renal cells and correlation with disease expression. J Clin Invest 93:1195-1207
83. Torra R, Badenas C, Cofan F, Callis L, Perez-Oller L, Darnell A (1999) Autosomal recessive Alport syndrome: linkage anal ysis and clinical features in two families. Nephrol Dial Transplant 14:627-630
84. Antignac C, Heidet L (1996) Mutations in Alport syndrome associated with diffuse esophageal leiomyomatosis. Contrib Nephrol 117:172-182
85. Antignac C, Zhou J, Sanak M, Cochat P, Roussel B, Deschenes G, Gros F, Knebelmann B, Hors-Cayla M-C, Tryggvason K, Gubler M-C (1992) Alport syndrome and diffuse leiomyomatosis: deletions in the 5′ end of the COL4A5 gene. Kidney Int 42:1178-1183
86. Zhou J, Mochizuki T, Smeets H, Antignac C, Laurila P, Paepe A de, Tryggvason K, Reeders ST (1993) Deletion of the paired α5(IV) and α6(IV) collagen genes in inherited smooth muscle tumors. Science 261:1167-1169
87. Heidet L, Dahan K, Zhou J, Xu Z, Cochat P, Gould JDM, Leppig KA, Proesmans W, Guyot C, Guillot M, Roussel B, Tryggvason K, Grunfeld JP, Gubler MC, Antignac C (1995) Deletions of both α5(IV) and α6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumors. Hum Mol Genet 4:99-108
88. Heidet L, Cohen-Solal L, Boye E, Thorner P, Kemper MJ, David A, Larget Piet L, Zhou J, Flinter F, Zhang X, Gubler MC, Antignac C (1997) Novel COL4A5/COL4A6 deletions and further characterization of the diffuse leiomyomatosis-Alport syndrome (DL-AS) locus define the DL critical region. Cytogenet Cell Genet 78:240-246
89. Segal Y, Peissel B, Renieri A, Marchi M de, Ballabio A, Pei Y, Zhou J (1999) LINE-1 elements at the sites of molecular rearrangements in Alport syndrome-diffuse leiomyomatosis. Am J Hum Genet 64:62-29
90. Ueki Y, Naito I, Oohashi T, Sugimoto M, Seki T, Yoshioka H, Sako Y, Sato H, Sawai T, Sasaki F, Matsuoka M, Fukuda S, Ninomiya Y (1998) Topoisomerase I and II consensus sequences in a 17-kb deletion junction of the COL4A5 and COL4A genes and immunohistochemical analysis of esophageal leiomyomatosis associated with Alport syndrome. Am J Hum Genet 62:253-261
91. Heiskari N, Zhang X, Zhou J, Leinenen A, Barker D, Gregory M, Atkin CL, Netzer KO, Weber M, Reeders S, Grohagenriska C, Neumann HPH, Trembath R, Tryggvason K (1996) Identification of 17 mutations in ten exons in the COL4A5 collagen gene, but no mutations found in four exons in COL4A6: a study of 250 patients with hematuria and suspected of having Alport syndrome. J Am Soc Nephrol 7:702-709
92. Wester DC, Atkin CL, Gregory MC (1995) Alport syndrome: clinical update. J Am Acad Audiol 6:73-79
93. Colville D, Savige J, Morfis M, Ellis J, Kerr P, Agar J, Fasset R (1997) Ocular manifestations of autosomal recessive Alport syndrome. Ophthalmic Genet 18:119-128
94. Colville DJ, Savige J (1997) Alport syndrome: a review of the ocular manifestations. Ophthalmic Genet 18:161-173
95. Nielsen CE (1978) Lenticonus anterior and Alport's syndrome. Arch Ophthalmol 56:518-530
96. Brownell RD, Wolter JR (1964) Anterior lenticonus in familial hemorrhagic nephritis: demonstration of lens pathology. Arch Ophthalmol 71:481-483
97. Kato T, Watanabe Y, Nakayasu K, Kanai A, Yajima Y (1998) The ultrastructure of the lens capsule abnormalities in Alport's syndrome. Jpn J Ophthalmol 42:401-405
98. Streeten BW, Robinson MR, Wallace R, Jones DB (1987) Lens capsule abnormalities in Alport's syndrome. Arch Ophthalmol 105:1693-1697
99. Perrin D, Jungers P, Grunfeld JP, Delons S, Noel LH, Zenatti C (1980) Perimacular changes in Alport's syndrome. Clin Nephrol 13:163-167
100. Polack BCP, Hogewind BL (1977) Macular lesions in Alport's disease. Am J Ophthalmol 84:533-535
101. Zylbermann R, Silverstone B-Z, Brandes E, Drukker A (1980) Retinal lesion in Alport's syndrome. J Pediatr Ophthalmol 17:255-260
102. Pajari H, Setala K, Heiskari N, Kaarianen H, Rosenlof K, Koskimies O (1999) Ocular findings in 34 patients with Alport syndrome: correlation of the findings to mutations in COL4A5 gene. Acta Ophthalmol Scand 77:214-217
103. Sabates R, Krachmer JH, Weingeist TA (1983) Ocular findings in Alport's syndrome. Ophthalmologica 186:204-210
104. Teekhasaenee C, Nimmanit S, Wutthiphan S, Vareesangthip K, Laohapand T, Malasitr P, Ritch R (1991) Posterior poly morphous dystrophy and Alport syndrome. Ophthalmology 98: 1207-1215
105. Thompson SM, Deady JP, Willshaw HE, White RHR (1987) Ocular signs in Alport's syndrome. Eye 1:146-153
106. Rhys C, Snyers B, Pirson Y (1997) Recurrent corneal erosion associated with Alport's syndrome. Kidney Int 52:208-211
107. Burke JP, Clearkin LG, Talbot JF (1991) Recurrent corneal epithelial erosions in Alport's syndrome. Acta Ophthalmol 69: 555-557
108. Jonsson A, Renieri A, Gallagher PG, Kashtan CE, Cherniske EM, Bruttinin M, Piccini M, Vitelli F, Ballabio A, Pober B (1998) Alport syndrome, mental retardation, midtace hypoplasia, and elliptocytosis: a new X linked contiguous gene deletion syndrome? J Med Genet 35:273-278
109. Piccini M, Vitelli F, Bruttini M, Pober B, Jonsson JJ, Villanova M, Zollo M, Borsani G, Ballabio A, Renieri A (1998) FACL4, a new gene encoding long-chain acyl-CoA synthetase 4, is deleted in a family with Alport syndrome, elliptocytosis, and mental retardation. Genomics 47:350-358
110. Vitelli F, Piccini M, Caroli F, Franco B, Malandrini A, Pober B, Jonsson J, Sorrentino V, Renieri A (1999) Identification and characterization of a highly conserved protein absent in the Alport syndrome (A), mental retardation (M), midface hypoplasia (M), and elliptocytosis (E) contiguous gene deletion syndrome. Genomics 55:335-340
111. Robson WLM, Lowry RB, Leung AKC (1994) X-linked recessive nephritis with mental retardation, sensorineural hearing loss, and macrocephaly. Clin Genet 45:314-317
112. Berheim J, Dechavanne M, Bryon PA, Lagarde M, Colon S, Pozet N, Traeger J (1976) Thrombocytopenia, macrothrombocytopathia, nephritis and deafness. Am J Med 61:145-150
113. Clare NM, Montiel MM, Lifschitz MD, Bannayan GA (1979) Alport's syndrome associated with macrothrombocytopenic thrombocytopenia. Am J Clin Pathol 72:111-117
114. Eckstein JD, Filip DJ, Watts JC (1975) Hereditary thrombocytopenia, deafness, and renal disease. Ann Intern Med 82: 639-645
115. Epstein CJ, Sahud MA, Piel CF, Goodman JR, Bernfield MR, Kushner JH, Ablin AR (1972) Hereditary macrothrombocytopenia, nephritis and deafness. Am J Med 52:299-310
116. Gutenberger J, Trygstan CW, Stiehm ER, Opitz JM, Thatcher LG, Bloodworth JMB (1970) Familial thrombocytopenia, elevated serum IgA levels and renal disease: a report of a kindred. Am J Med 49:729-741
117. Hansen MS, Behnke O, Pedersen NT, Videbaek A (1978) Macrothrombocytopenia associated with glomerulonephritis, deafness and aortic cystic media necrosis. Scand J Hematol 21: 197-205
118. Parsa KP, Lee DBN, Zamboni L, Glassock RJ (1976) Hereditary nephritis, deafness and abnormal thrombopoiesis: study of a new kindred. Am J Med 60:665-671
119. Peterson LC, Rao KV, Crosson JT, White JG (1985) Fechtner syndrome: a variant of Alport's syndrome with leukocyte inclusions and macrothrombocytopathia. Blood 65: 397-406
120. Naito I, Nomura S, Inoue S, Kagawa M, Kawai S, Gunshin Y, Joh K, Tsukidate C, Sado Y, Osawa G (1997) Normal distribution of collagen IV in renal basement membranes in Epstein's syndrome. J Clin Pathol 50:919-922